Bioethicists 23andMe genetic testing

The company 23andMe had ambitious plans to sign up a million new consumers for its direct-to-consumer genetic testing service until the FDA ordered it to stop marketing its at-home testing kit. In the ensuing debate, a pair of influential voices have weighed in -- on the side of the FDA.
Copyright © 2016, Los Angeles Times